Home vs. hospital treatment for mild pulmonary embolism
Part of Heart & circulation, Lungs & breathing clinical trials.
This trial compares treating blood clots in the lungs (pulmonary embolism) at home versus in the hospital. It is for people who are stable enough to go home but show signs of extra heart strain or high troponin levels.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You have a confirmed pulmonary embolism (blood clot in the lung)
- Your vital signs are stable and you don't need to stay in the hospital based on a standard checklist (Hestia rule)
- You have signs of extra heart strain on an echocardiogram or CT scan, or a slightly high troponin level in your blood
- You have health insurance as required by local laws
- You can give consent to participate
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two treatments for a serious type of blood clot in the lungs called acute intermediate-high risk pulmonary embolism. It tests whether clot-busting medicine is better than a catheter procedure to clear the clot and help you recover.
This study tests whether healthy living tips and messages sent daily by text or email can help you recover better after a serious blood clot in your lung called a pulmonary embolism. It may be a good fit if you are already taking a blood thinner and can receive text messages.
This study tests whether people with active cancer and a new blood clot in the lung can be safely treated at home instead of in the hospital. If you have cancer and a blood clot that is not causing severe symptoms, you may be able to join this trial.
This real-world study compares different treatment approaches for pulmonary embolism (PE)—a serious blood clot in the lung arteries—in patients who are stable but at intermediate-to-high risk of complications. The goal is to understand which treatments work best and safest in everyday practice.
This trial compares three treatments for an intermediate-high risk pulmonary embolism: a minimally invasive clot removal procedure (embolectomy), a low-dose clot-dissolving medication, or standard blood thinning (heparin). The goal is to see which approach works best to prevent worsening while reducing bleeding risks.
This study looks at how well a catheter (a thin tube) works to treat a serious type of blood clot in the lungs. It is for people who have a large clot that is causing problems like fast heart rate or low blood pressure.
Hear when a new Acute Pulmonary Embolism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.